Analysts say the departure of the CBER head may alleviate overhang in the cell and gene therapy space. Vinay Prasad, head of the Center for Biologics Evaluation and Research (CBER) at the US Food and ...

EDITORIAL: A recommitment to the foundational moral and ethical principle that all life is sacred, at every stage, is needed.

The Trump administration has gone after Harvard University since April. It has cut billions in funding while also demanding ...

Newsroom is open 24 hours, please reach us by email at [email protected] or by phone Monday through Friday 9-5. You can ...

Recently, the state lost a $50 billion opportunity to woo a major drug manufacturer to our shores. Wes Moore was asleep at ...

Burns' position was noted in an April memo from CDC chief of staff Matt Buzzelli that was obtained by MedPage Today editor-in ...

The Senate voted 51-47 on July 29 to confirm Susan Monarez, PhD, as the new CDC director following her nomination by President Donald Trump in March. Dr. Monarez has served as acting CDC director ...

According to a July report from HHS’ Office of Inspector General, hospitals failed to capture 49% of patient harm events because staff either did not consider them harmful or were not required to ...

Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and was later named chief medical and scientific officer.

HHS moves to schedule 7-hydroxymitragynine (7-OH) despite no confirmed deaths linked to the compound Critics say the decision ...

HHS Secretary RFK Jr is considering removing all 16 members of an advisory group that helps decide which preventive services should be fully covered by insurance.

Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug Administration (FDA) and a critic of the agency’s COVID-19 policies, has departed after being on the job ...